{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:08Z","timestamp":1761102248863},"publisher-location":"Berlin, Heidelberg","reference-count":28,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783662561379"},{"type":"electronic","value":"9783662561386"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/8904_2016_37","type":"book-chapter","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T06:49:56Z","timestamp":1485240596000},"page":"49-57","source":"Crossref","is-referenced-by-count":12,"title":["What Is the Best Blood Sampling Time for Metabolic Control of Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients?"],"prefix":"10.1007","author":[{"given":"Esther","family":"van Dam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gineke","family":"Venema-Liefaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry G. J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rebecca Heiner-Fokkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francjan J.","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpeds.2013.10.001","volume":"164","author":"F Bendadi","year":"2014","unstructured":"Bendadi F, de Koning TJ, Visser G et al (2014) Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone. J Pediatr 164:398\u2013401","journal-title":"J Pediatr"},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 376:1417\u20131427","journal-title":"Lancet"},{"key":"37_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-642-15720-2_18","volume-title":"Inborn metabolic diseases-diagnosis and treatment","author":"A Chakrapani","year":"2012","unstructured":"Chakrapani A, Gissen P, McKiernan P (2012) Disorders of tyrosine metabolism. In: Saudubray J, van den Berghe G, Walter JH (eds) Inborn metabolic diseases-diagnosis and treatment. Springer, Berlin, pp 265\u2013276"},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-277X.2011.01215.x","volume":"25","author":"A Daly","year":"2012","unstructured":"Daly A, Gokmen-Ozel H, MacDonald A, Preece MA, Davies P, Chakrapani A, McKiernan P (2012) Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned? J Hum Nutr Diet 25:111\u2013116","journal-title":"J Hum Nutr Diet"},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1469-8749.2011.04048.x","volume":"53","author":"C Laet de","year":"2011","unstructured":"de Laet C, Munoz VT, Jaeken J et al (2011) Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1. Dev Med Child Neurol 53:962\u2013964","journal-title":"Dev Med Child Neurol"},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","volume":"8","author":"C Laet de","year":"2013","unstructured":"de Laet C, Dionisi-Vici C, Leonard JV et al (2013) Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 8:8","journal-title":"Orphanet J Rare Dis"},{"key":"37_CR7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/cclm.2010.271","volume":"48","author":"V De Silva","year":"2010","unstructured":"De Silva V, Oldham CD, May SW (2010) L-phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods. Clin Chem Lab Med 48:1271\u20131279","journal-title":"Clin Chem Lab Med"},{"key":"37_CR8","first-page":"224","volume":"39","author":"DL Farquhar","year":"1985","unstructured":"Farquhar DL, Steven F, Westwood A (1985) Preliminary report on inverse diurnal variation of phenylalanine: implications in maternal phenylketonuria. Hum Nutr Appl Nutr 39:224\u2013226","journal-title":"Hum Nutr Appl Nutr"},{"key":"37_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/GIM.0b013e318159a355","volume":"9","author":"CO Gregory","year":"2007","unstructured":"Gregory CO, Yu C, Singh RH (2007) Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods. Genet Med 9:761\u2013765","journal-title":"Genet Med"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinbiochem.2014.09.014","volume":"48","author":"U Groselj","year":"2015","unstructured":"Groselj U, Murko S, Zerjav Tansek M, Kovac J, Trampus Bakija A, Repic Lampret B, Battelino T (2015) Comparison of tandem mass spectrometry and amino acid analyzer for phenylalanine and tyrosine monitoring \u2013 implications for clinical management of patients with hyperphenylalaninemia. Clin Biochem 48:14\u201318","journal-title":"Clin Biochem"},{"key":"37_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2006.04.013","volume":"373","author":"M Holub","year":"2006","unstructured":"Holub M, Tuschl K, Ratschmann R et al (2006) Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. Clin Chim Acta 373:27\u201331","journal-title":"Clin Chim Acta"},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.jchromb.2009.09.045","volume":"877","author":"R Kand\u2019\u00e1r","year":"2009","unstructured":"Kand\u2019\u00e1r R, Zakova P (2009) Determination of phenylalanine and tyrosine in plasma and dried blood samples using HPLC with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 877:3926\u20133929","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2012.05.022","volume":"107","author":"J Larochelle","year":"2012","unstructured":"Larochelle J, Alvarez F, Bussieres JF et al (2012) Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Quebec. Mol Genet Metab 107:49\u201354","journal-title":"Mol Genet Metab"},{"key":"37_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0969141315593571","volume":"23","author":"AJ Lawson","year":"2016","unstructured":"Lawson AJ, Bernstone L, Hall SK (2016) Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit. J Med Screening 23:7\u201316","journal-title":"J Med Screening"},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/adc.78.2.122","volume":"78","author":"A MacDonald","year":"1998","unstructured":"MacDonald A, Rylance GW, Asplin D, Hall SK, Booth IW (1998) Does a single plasma phenylalanine predict quality of control in phenylketonuria? Arch Dis Child 78:122\u2013126","journal-title":"Arch Dis Child"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcn\/39.5.722","volume":"39","author":"TJ Maher","year":"1984","unstructured":"Maher TJ, Glaeser BS, Wurtman RJ (1984) Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake. Am J Clin Nutr 39:722\u2013729","journal-title":"Am J Clin Nutr"},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","volume":"31","author":"A Masurel-Paulet","year":"2008","unstructured":"Masurel-Paulet A, Poggi-Bach J, Rolland MO et al (2008) NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis 31:81\u201387","journal-title":"J Inherit Metab Dis"},{"key":"37_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-014-0107-7","volume":"9","author":"S Mayorandan","year":"2014","unstructured":"Mayorandan S, Meyer U, Gokcay G et al (2014) Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet J Rare Dis 9:107","journal-title":"Orphanet J Rare Dis"},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinbiochem.2013.05.047","volume":"46","author":"XM Mo","year":"2013","unstructured":"Mo XM, Li Y, Tang AG, Ren YP (2013) Simultaneous determination of phenylalanine and tyrosine in peripheral capillary blood by HPLC with ultraviolet detection. Clin Biochem 46:1074\u20131078","journal-title":"Clin Biochem"},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/978-3-642-40337-8_49","volume-title":"Physician\u2019s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases","author":"M Pasquali","year":"2014","unstructured":"Pasquali M, Longo N (2014) Amino acids. In: Blau N, Duran M, Gibson KM, Dionisi-Vici C (eds) Physician\u2019s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases. Springer, Berlin, pp 749\u2013759"},{"key":"37_CR21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-3476(66)80327-X","volume":"69","author":"BM Rouse","year":"1966","unstructured":"Rouse BM (1966) Phenylalanine deficiency syndrome. J Pediatr 69:246\u2013249","journal-title":"J Pediatr"},{"key":"37_CR22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","volume":"65","author":"I Smith","year":"1990","unstructured":"Smith I, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65:472\u2013478","journal-title":"Arch Dis Child"},{"key":"37_CR23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10545-012-9491-0","volume":"35","author":"R Teissier","year":"2012","unstructured":"Teissier R, Nowak E, Assoun M et al (2012) Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation. J Inherit Metab Dis 35:993\u2013999","journal-title":"J Inherit Metab Dis"},{"key":"37_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.92.4.570","volume":"92","author":"FJ Spronsen van","year":"1993","unstructured":"van Spronsen FJ, van Rijn M, van Dijk T, Smit GP, Reijngoud DJ, Berger R, Heymans HS (1993) Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting\/postprandial) in patients with phenylketonuria: effect of sample timing. Pediatrics 92:570\u2013573","journal-title":"Pediatrics"},{"key":"37_CR25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ajcn\/64.6.916","volume":"64","author":"FJ Spronsen van","year":"1996","unstructured":"van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS (1996) Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am J Clin Nutr 64:916\u2013921","journal-title":"Am J Clin Nutr"},{"key":"37_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2014_358","volume":"18","author":"D Vliet van","year":"2014","unstructured":"van Vliet D, van Dam E, van Rijn M et al (2014) Infants with tyrosinemia type 1: should phenylalanine be supplemented? JIMD Rep 18:117","journal-title":"JIMD Rep"},{"key":"37_CR27","unstructured":"Westenbrink S, Jansen-van der Vliet M (2010) NEVO-tabel Nederlands voedingsbestand 2010"},{"key":"37_CR28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1023\/A:1005666426079","volume":"23","author":"CJ Wilson","year":"2000","unstructured":"Wilson CJ, Van Wyk KG, Leonard JV, Clayton PT (2000) Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia. J Inherit Metab Dis 23:677\u2013683","journal-title":"J Inherit Metab Dis"}],"container-title":["JIMD Reports","JIMD Reports, Volume 36"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2016_37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T16:30:14Z","timestamp":1658507414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2016_37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783662561379","9783662561386"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/8904_2016_37","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"type":"print","value":"2192-8304"},{"type":"electronic","value":"2192-8312"}],"subject":[],"published":{"date-parts":[[2017]]}}}